| Chengdu Kanghong Pharmaceutical Group Co., Ltd. engages in the research, manufacture and distribution of biological products, traditional Chinese medicines, and chemical drugs. Its products include conbercept ophthalmic injection, songling xuemaikang jiaonang, shugan jieyu jiaonang, kenuoxin jiaonang, danshu jiaonang, yiqing jiaonang, venlafaxine hydrochloride capsules and sustained-release tablets, aripiprazole tablets and orally disintergrating tablets, mosapride citrate dispersible tablets, and dexzopiclone tablet. The company was founded on October 3, 1996 and is headquartered in Chengdu, China. |
